Share
Marco Campione
Blue Earth Diagnostics Ltd, a Bracco company and leader in the development of innovative PET radiopharmaceuticals, has announced the appointment of Marco Campione as Chief Executive Officer (CEO). Campione will report to Fulvio Renoldi Bracco, CEO of Bracco Imaging, and will also join the Blue Earth Diagnostics Ltd Board of Directors.
Additionally, he will serve as Vice Chair of the Blue Earth Diagnostics Inc. Board of Directors. This appointment coincides with Dr. David Gauden, a co-founder of Blue Earth Diagnostics, transitioning to the role of full-time CEO of Blue Earth Therapeutics, a Bracco subsidiary.
Fulvio Renoldi Bracco, CEO of Bracco Imaging, expressed confidence in Campione's leadership, stating, "We are thrilled to welcome Marco at this transformative time for our company. His strategic and operational expertise will be pivotal as Blue Earth Diagnostics continues its global expansion and leadership in the diagnostic radiopharmaceutical industry." Bracco also acknowledged Dr. Gauden's significant contributions to Blue Earth's success and wished him well in his new role at Blue Earth Therapeutics.
Campione, who brings over 25 years of experience from GE HealthCare, where he most recently served as Executive Director and Global Head of Contrast Media, shared his excitement: "I am honored to take on the role of CEO at Blue Earth Diagnostics. The company has built a strong reputation for innovation and patient-centric service. I look forward to expanding our PET imaging products for prostate cancer and advancing new programs in neuro-oncology and solid tumors."
This leadership transition reflects a strategic vision aimed at continuing the growth and innovation that has characterized Blue Earth's success to date.
